Lenacapavir shot may offer long-term HIV protection

geneticliteracyproject.org

A new annual injection of the drug lenacapavir has shown promise in providing long-term protection against HIV, potentially revolutionizing prevention efforts. Clinical trials demonstrated lenacapavir's effectiveness, with 100% protection in women and girls. The drug, already approved for HIV treatment, requires only two injections per year for full protection. A recent phase I trial confirmed the drug's presence in participants' blood a year after injection, suggesting continued protection. This could be a major step towards ending the HIV epidemic.


With a significance score of 4.1, this news ranks in the top 5.7% of today's 28277 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: